Business Parks & Science Centres

 
 
 

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5658 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 15 16 17 ... 55 56 57  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Epigenomics–SEVERAL: investment, 201605 private placement €6.8m w 1.436m new shares at €4.76/share led by BioChain (55%) 2016-05-24
MorphoSys–Univ Texas: antibody cancer drug, 201605– collab strategic alliance r+d using Ylanthia technology with MD Anderson ORBIT unit 2016-05-24
Xenikos–MC Services: public relations, 201605 service existent for Xenikos BV by MC Services AG Düsseldorf 2016-05-24
Boehringer–BioMed X: pharma research, 201605– collab new BioMed X research group to discover new treatm options for psychiatric diseases 2016-05-23
Univ Birmingham–Bruker Corp: NMR spectrometer, 201605 supply two 600MHz NMR systems w room temperature 5mm probe at PCB 2016-05-23
Univ Birmingham–Thermo Fisher: mass spectrometer, 201605 supply one Orbitrap Elite MS system w nanoLC + 2D-LC + Advion Triversa Nanomate at PCB 2016-05-23
Univ Birmingham–Thermo Fisher: mass spectrometer, 201605 supply Q Exactive Plus MS system at Birmingham Metabolomics Training Centre 2016-05-23
Univ Birmingham–Thermo Fisher: mass spectrometer, 201605 supply three Q Exactive Focus MS systems w Ultimate3000 RSLC UHPLC systems at PCB 2016-05-23
Univ Birmingham–Thermo Fisher: mass spectrometer, 201605 supply two Quantiva triple quad MS systems w Ultimate3000 RSLC UHPLC systems at PCB 2016-05-23
Univ Birmingham–United Kingdom (govt): grant, 201411–201605c award £8m for new Phenome Centre Birmingham from MRC + 4 instrument firms + the Univ 2016-05-23
Monsanto–Bayer: investment, 201605– acquisiton unsolicited $66b all-cash offer $128/share by Bayer 2016-05-19
Medigene–BioNTech: cell therapy, 201605– supply + collab process developm to produce TCR-modified T cells by Eufets GmbH 2016-05-18
Bayer–ERS Genomics: CRISPR technology, 201605– license €na to patents for certain cross-divisional applications in Bayer’s core strategic areas 2016-05-17
NousCom–Life Sciences Partners: investment, 201605 financing round Series A totalling €12m co-led by LSP + Versant Ventures 2016-05-17
NousCom–SEVERAL: investment, 201605 financing round Series A €12m co-led by LSP + Versant Ventures 2016-05-17
NousCom–Versant Ventures: investment, 201605 financing round Series A totalling €12m co-led by LSP + Versant Ventures 2016-05-17
Caribou Biosciences–Novartis: investment, 201605 financing round Series B totalling $30m incl existing investor Novartis 2016-05-16
Caribou Biosciences–SEVERAL: investment, 201605 financing round Series B $30m from new + existing investors 2016-05-16
EndoStim–Gimv: investment, 201605 financing round Series D totalling $25m incl $2.7m from Gimv Health & Care 2016-05-12
EndoStim–SEVERAL: investment, 201605 financing round Series D $25m led by Endeavour Vision + incl Santé Ventures + Gimv + Wellington Partners et al 2016-05-12
Boehringer–Max Planck: CNS drug, 201605– Boehringer acquires option for excl rights to new schizophrenia lead compound from LDC 2016-05-11
Bayer–BioNTech: mRNA technology, 201605– collab €na developm mRNA vaccines + therapeutics for animal use 2016-05-10
BioNTech–Bayer: investment, 201605 investment €na by BLSC in connection with animal health mRNA collaboration 2016-05-10
Novimmune–SEVERAL: investment, 201605 financing round CHF30m from existing shareholders 2016-05-10
AC Immune–SEVERAL: investment, 201605 private financing round Series E CHF42.7m 2016-05-09
Expedeon–Genetrix (ES): investment, 201605–201608 acquisition of Expedeon Holdings Ltd by Sygnis AG for €1.7m cash + na shares 2016-05-09
Genetrix (ES)–SEVERAL: investment, 201605–201607 capital increase Sygnis AG €5.3m w 3m rights offering + 1.8m shares private placement €1.1/share 2016-05-09
LabCorp–Epigenomics: molecular diagnostics cancer test, 201605– distribution LabCorp to offer Epi proColon test in the US 2016-05-09
Alrise Biosystems–Creathor Venture: investment, 201605 existent Alrise listed as current investment on web site of Creathor 2016-05-06
Ayoxxa–Creathor Venture: investment, 201605 existent Ayoxxa listed as current investment on web site of Creathor 2016-05-06
CAP-CMV GmbH–Creathor Venture: investment, 201605 existent CAP-CMV listed as current investment on web site of Creathor 2016-05-06
Caprotec–Creathor Venture: investment, 201605 existent Caprotec listed as current investment on web site of Creathor 2016-05-06
Cevec–Creathor Venture: investment, 201605 existent Cevec listed as current investment on web site of Creathor 2016-05-06
Chundsell Medicals–Creathor Venture: investment, 201605 existent Chundsell listed as current investment on web site of Creathor 2016-05-06
Cube Biotech–Creathor Venture: investment, 201605 existent Cube Biotech listed as current investment on web site of Creathor 2016-05-06
Klara–Creathor Venture: investment, 201605 existent Klara listed as current investment on web site of Creathor 2016-05-06
Phenex–Creathor Venture: investment, 201605 existent Phenex listed as current investment on web site of Creathor 2016-05-06
Sirion Biotech–Creathor Venture: investment, 201605 existent Sirion Biotech listed as current investment on web site of Creathor 2016-05-06
Sividon Diagnostics–Creathor Venture: investment, 201605 existent Sividon listed as current investment on web site of Creathor 2016-05-06
Euticals–Albany Molecular: investment, 201604–201607 acquisition €315m in cash + stock + a seller note of Prime European Therapeuticals SpA by AMRI 2016-05-05
TU Munich–Werner Siemens Foundation: grant, 201605– donation €11.5m to promote synthetic biotechnology in new TUM School of Bioengineering 2016-05-04
Vaximm–MC Services: public relations, 201605 service existent for Vaximm by MC Services AG 2016-05-04
Ideaya Biosciences–Novartis: investment, 201605 financing round Series A totalling $46m including investor Novartis Institute of Biomedial Research 2016-05-03
Ideaya Biosciences–SEVERAL: investment, 201605 financing round Series A $46m from 5AM Ventures + Canaan Ventures + NIBR et al 2016-05-03
IMS Health–Quintiles: investment, 201603–201610 merger $10.4b into Quintiles IMS w former IMS owners holding 51.4% after merger 2016-05-03
Eppendorf–Bio-ITech: bioinformatics, 201605 collab product integration of eLabJournal ELN with Eppendorf instruments shown at Analytica 2016 2016-05-02
PathoSept project–North Rhine-Westphalia (govt): grant, 201605– LifeSciences.NRW grant €3.5m to develop rapid test for serious infections 2016-05-01
PRECIOUS project (2)–EU (govt): grant, 201605–202104 Horizon 2020 grant €8.3m to develop cancer immuntherapeutic nanomedicine led by Radboud Univ 2016-05-01
Roche–Evotec: drug discovery services, 201605–201904 collab extension for 3 years discovery small molecule drugs for Genentech 2016-05-01
4SC–BioNTech: investment, 201604 acquisition €650k of all key operating assets + employees of 4SC Discovery GmbH by new BioNTech Small Molecules GmbH 2016-04-29
Glycotope–Consilium: public relations, 201604 service existent by CSC 2016-04-29
Novartis–BioQ Pharma: pharmaceutical, 201604– expansion excl license + supply agreem for one more for ready-to-use infusion product to Sandoz in US 2016-04-28
Sayre Therapeutics–Oncgnostics: cervical cancer test, 201604– distribution excl of GynTect test in India et al by Sayre Therapeutics Pvt Ltd 2016-04-28
Bentekk–Hamburg (govt): investment, 201604 seed funding 6-digit €na from HTGF + Innovationsstarter Fonds Hamburg 2016-04-27
Bentekk–High-Tech Gründerfonds: investment, 201604 seed funding 6-digit €na from HTGF + Innovationsstarter Fonds Hamburg 2016-04-27
Bentekk–SEVERAL: investment, 201604 seed funding 6-digit €na from HTGF + Innovationsstarter Fonds Hamburg 2016-04-27
Boehringer–VTU: recombinant protein production, 201604– collab ww expansion of agreem for Pichia pastoris technology + incl E coli platform 2016-04-27
UBS–MPM Capital: fund management, 201604– collab MPM is advisor to new $471m UBS Oncology Impact Fund 2016-04-27
UBS–SEVERAL: investment, 201604 final closing of $471m UBS Oncology Impact Fund which will be advised by MPM Capital 2016-04-27
Evotec–Exscientia: cancer immunotherapy, 201604– collab r+d bi-specific small molecule immuno-oncology therapies co-owned + risk-shared 2016-04-26
Wilex–SEVERAL: investment, 201604 capital increase €4.13m with 2.25m new shares at €1.84/share whereof >50% to Dievini Hopp 2016-04-25
Aptuit–Welsh Carson Anderson & Stowe: investment, 201604 existent Aptuit LLC is portfolio company of WCAS 2016-04-21
Exquiron Biotech–Aptuit: investment, 201604 acquisition by Aptuit LLC 2016-04-21
F-Star–Hume Brophy: public relations, 201604 service existent by Hume Brophy London 2016-04-21
Enterome–BPCE: investment, 201604 financing round Series C totalling €14.5m incl co-lead + existing investor Seventure Partners 2016-04-20
Enterome–Lundbeck: investment, 201604 financing round Series C totalling €14.5m incl co-lead + existing investor Lundbeckfond Ventures 2016-04-20
Enterome–Nestlé: investment, 201604 financing round Series C totalling €14.5m incl new + co-investor Nestlé Health Science 2016-04-20
Enterome–SEVERAL: investment, 201604 financing round Series C €14.5m led by Seventure Partners + Lundbeckfond Ventures plus Nestlé Health et al 2016-04-20
Second Genome–Roche: investment, 201604 financing round Series B totalling $42.6m co-led by Pfizer Venture Investments + Roche Venture Fund 2016-04-20
Second Genome–SEVERAL: investment, 201604 financing round Series B $42.6m co-led by Pfizer Venture Investments + Roche Venture Fund 2016-04-20
Univ Lausanne–Saphetor: bioinformatics, 201604– supply CHUV to use Saphetor’s precision medicine platform for research + clinical applications 2016-04-20
G-Therapeutics–Gimv: investment, 201604 financing round Series A totalling €26m incl co-investor Gimv 2016-04-19
G-Therapeutics–Netherlands (govt): credit, 201604 deferred risk-bearing innovation loan €10m from RvO 2016-04-19
G-Therapeutics–SEVERAL: investment, 201604 financing round Series A €26m co-led by LSP + INKEF Capital + Gimv + Wellington Partnes 2016-04-19
HMNC–R-Biopharm: molecular companion diagnostics, 201604– collab €na developm PCR-based ABCB1 CDx for depression therapy 2016-04-19
Minapharm–Eucodis: ADC technology, 201604– license excl for C-LiNK (CTAT) technology to ProBioGen 2016-04-19
Pierre Fabre–Evotec: compound management, 201604–201103 supply service €na sample management for Pierre Fabre by Evotec Toulouse 2016-04-19
Hopp Group–Promethera: investment, 201604 acquisition of key assets of Cytonet in shares w Hopp family holding up to 13% of Promethera afterwards 2016-04-18
Promethera–Hopp Group: investment, 201604 Hopp family holding up to 13% of Promethera after sale of key assets of Cytonet to Promethera 2016-04-18
Crelux–WuXi PharmaTech: investment, 201604 acquisition of Crelux GmbH by WuXi AppTec 2016-04-15
Agena Bioscience–Horizon Discovery: reference standards, 201604– supply + distribution agreem for iPLEX standards for MassARRAY oncology assays 2016-04-14
GeNeuro–SEVERAL: investment, 201604 IPO €33m+€1k IPO with 2.54m+9.4k new shares at Euronext Paris 2016-04-14
Mirati–Qiagen: molecular companion diagnostics, 201604– collab developm + commercialisation of RNA-based CDx for glesatinib 2016-04-13
Forbion–SEVERAL: investment, 201604 final closing €183m of FCF III Fund incl EIF + DVI + FkW + Charles River Labs + Knight Therapeutics 2016-04-12
KWS Saat–HZPC: investment, 201604 acquisition €na of conventional seed potato business of KWS by Stet Holland BV 2016-04-11
STAT-Diagnostica–Boehringer: investment, 201604 financing round Series C totalling €25m incl returning co-investor BIVF 2016-04-11
STAT-Diagnostica–Gilde Investment: investment, 201604 financing round Series C totalling €25m incl led + new investor Gilde Healthcare 2016-04-11
STAT-Diagnostica–SEVERAL: investment, 201604 financing round Series C €25m led by new investor Gilde Healthcare 2016-04-11
United States (govt)–Evolva: biomaterials, –201604 collab CRADA to develop new materials for the US Navy 2016-04-11
Cunesoft–Bavaria (govt): investment, 201604 financing round Series A 7-digit €na incl returning co-investor Bayern Kapital 2016-04-07
Cunesoft–High-Tech Gründerfonds: investment, 201604 financing round Series A 7-digit €na incl returning co-investor HTGF 2016-04-07
Cunesoft–Occident Group: investment, 201604 financing round Series A 7-digit €na incl new + lead investor Occident Group AG 2016-04-07
Cunesoft–SEVERAL: investment, 201604 financing round Series A 7-digit €na led by Occident Group + incl HTGF + Bayern Kapital 2016-04-07
Bayer–Meiogenix: plant breeding technology, 201604– license non-excl €na to SpiX technology for Bayer CropScience 2016-04-06
Lumos Pharma–Roche: investment, 201604 financing round Series B totalling $34m incl new co-investor Roche Venture Fund 2016-04-06
Lumos Pharma–SEVERAL: investment, 201604 financing round Series B $34m led by Deerfield Management Co plus Roche VF + UCB et al 2016-04-06
Lumos Pharma–UCB: investment, 201604 financing round Series B totalling $34m incl existing + co-investor UCB 2016-04-06
Thermosome–Bavaria (govt): investment, 201604 1st financing round totalling €1.9m incl HTGF + Bayern Kapital + private investors 2016-04-06
Thermosome–Germany (govt): grant, 201604– BMBF grant €2.7m 3y as part of TSL-LIFU project consortium 2016-04-06
Thermosome–High-Tech Gründerfonds: investment, 201604 1st financing round totalling €1.9m incl HTGF + Bayern Kapital + private investors 2016-04-06
next pagenext page 1 2 3 ... 15 16 17 ... 55 56 57  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top